Adcock Richard's Form 4 filing
ImmunityBio, Inc. (IBRX) · filed Oct 8, 2021
- Accession no.
- 0001326110-21-000005
- Filed
- Oct 8, 2021
- Trade date
- Oct 8, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $17.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Adcock RichardCIK 0001830328 | Director, Officer (CEO & President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2021 | Common Stock | PPurchaseAcquired | +7 | $9.00 | +$63 | 7 | Indirect | |
| Oct 8, 2021 | Common Stock | PPurchaseAcquired | +1,923 | $8.81 | +$16,941.63 | 1,930 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.